)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Forte Biosciences (FBRX) investor relations material
Forte Biosciences Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary14 Nov, 2025
Executive summary
FB102 advanced with positive Phase 1b celiac disease data; Phase 2 celiac and Phase 1b vitiligo and alopecia areata trials ongoing, with topline data for all three expected in 2026.
US IND for FB102 is open, enabling expanded enrollment in the celiac disease Phase 2 trial at US sites.
$93.4 million in cash and cash equivalents as of September 30, 2025, following $75 million public offering and $53 million private placement.
No commercial revenue; focus remains on clinical development and expanding indications for FB102.
Financial highlights
Net loss of $17.7 million for Q3 2025, up from $8.4 million in Q3 2024; net loss of $44.6 million for the nine months ended September 30, 2025, compared to $28.3 million in the prior year period.
Research and development expenses rose to $15.2 million in Q3 2025 (from $5.9 million in Q3 2024), mainly due to increased clinical and manufacturing costs.
General and administrative expenses were $3.2 million in Q3 2025 (up from $2.8 million), driven by higher personnel costs.
Net loss per share was $(0.99) for Q3 2025 versus $(4.54) for Q3 2024; for the nine months ended September 30, 2025, net loss per share was $(3.26) compared to $(15.35) in 2024.
Ended Q3 2025 with $93.4 million in cash and cash equivalents.
Outlook and guidance
Topline results for FB102 in celiac disease, vitiligo, and alopecia areata expected in 2026.
Cash runway expected to fund operations for at least 12 months from the filing date.
Additional capital will be required to complete development and commercialization of FB102.
R&D expenses may increase as clinical programs expand and new indications are pursued.
General and administrative expenses may fluctuate with infrastructure and advisory needs.
How FB102 differentiates in celiac disease?
Cash runway given increasing R&D spend?
Prioritization of FB102's multiple indications?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Forte Biosciences earnings date
Q4 202527 Mar, 2026
Next Forte Biosciences earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Forte Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases and inflammatory skin conditions. The company is engaged in the research and development of new treatments targeting unmet medical needs. Forte Biosciences operates within the healthcare and biotechnology sectors. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage